Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This gene (ENSG00000298604) is annotated by Ensembl as a novel transcript that is antisense to the protein-coding HACD2 gene[1][3][5]. There is no evidence that ENSG00000298604 encodes a protein, receptor, or other canonical drug target molecule. It is cataloged as a long non-coding RNA (lncRNA), typically considered to have regulatory—but not directly druggable—functions. There are no known aliases beyond its database identifiers, and there are no associated molecular functions, disease roles, or interactions with drugs documented in current resources. As such, it is not considered a validated or conventional therapeutic target, and the information available is too limited for further classification. Note: The request is affected by the non-specific nature of this target: ENSG00000298604 is not a confirmed receptor, enzyme, or drug target; it is *likely a non-coding RNA* whose function, role in disease, and potential as a therapeutic target are uncharacterized or unknown[5]. If your goal is to retrieve information on the adjacent protein-coding gene (HACD2; 3-hydroxyacyl-CoA dehydratase 2), which is functionally relevant in mitochondrial lipid metabolism and disease, please specify—HACD2 is a well-established enzyme and potential target, while ENSG00000298604 is likely nonfunctional in the conventional sense and not a direct therapeutic target[11].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on novel transcript, antisense to HACD2.